|
Volumn 22, Issue 14, 2012, Pages 4778-4782
|
Synthesis and biological evaluation of novel 4β-(1,3,4-oxadiazole-2- amino)-podophyllotoxin derivatives
|
Author keywords
1,3,4 Oxadiazole; Antitumor activity; Mechanism; Podophyllotoxin; Topoisomerase II
|
Indexed keywords
1,3,4 OXADIAZOLE DERIVATIVE;
4BETA (1,3,4 OXADIAZOLE 2 AMINO)PODOPHYLLOTOXIN DERIVATIVE;
DNA TOPOISOMERASE (ATP HYDROLYSING);
ETOPOSIDE;
FLUOROURACIL;
PODOPHYLLOTOXIN;
PODOPHYLLOTOXIN DERIVATIVE;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
ARTICLE;
CELL STRAIN HEPG2;
CONTROLLED STUDY;
CYTOTOXICITY;
DRUG POTENCY;
DRUG SELECTIVITY;
DRUG SYNTHESIS;
ENZYME ACTIVITY;
HELA CELL;
HUMAN;
HUMAN TISSUE;
IN VITRO STUDY;
S PHASE CELL CYCLE CHECKPOINT;
TUMOR CELL LINE;
VERO CELL;
ANIMALS;
CELL LINE;
CELL SURVIVAL;
GENE EXPRESSION REGULATION, ENZYMOLOGIC;
HUMANS;
MOLECULAR STRUCTURE;
PODOPHYLLOTOXIN;
STRUCTURE-ACTIVITY RELATIONSHIP;
TOPOISOMERASE I INHIBITORS;
TOPOISOMERASE II INHIBITORS;
|
EID: 84863460053
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2012.05.059 Document Type: Article |
Times cited : (52)
|
References (19)
|